Gudkov Andrei V 4
4 · CLEVELAND BIOLABS INC · Filed Apr 19, 2010
Insider Transaction Report
Form 4
Gudkov Andrei V
DirectorChief Scientific Officer
Transactions
- Sale
Common Stock
2010-04-16$3.61/sh−3,900$14,079→ 1,509,600 total - Sale
Common Stock
2010-04-16$3.60/sh−800$2,880→ 1,513,500 total - Sale
Common Stock
2010-04-16$3.62/sh−100$362→ 1,514,300 total - Sale
Common Stock
2010-04-16$3.59/sh−200$718→ 1,514,400 total
Holdings
- 174,750
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying) - 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying)
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and represent approximately 0.3% of the reporting person's 1,549,600 shares held prior to adoption of the plan. The maximum sales subject to the plan in its entirety represent approximately 3.9% of the reporting person's shares held prior to adoption of the plan.